Generalizability of clinical prediction models in mental health.

Publication date: Aug 01, 2025

Concerns about the generalizability of machine learning models in mental health arise, partly due to sampling effects and data disparities between research cohorts and real-world populations. We aimed to investigate whether a machine learning model trained solely on easily accessible and low-cost clinical data can predict depressive symptom severity in unseen, independent datasets from various research and real-world clinical contexts. This observational multi-cohort study included 3021 participants (62. 03% females, M = 36. 27 years, range 15-81) from ten European research and clinical settings, all diagnosed with an affective disorder. We firstly compared research and real-world inpatients from the same treatment center using 76 clinical and sociodemographic variables. An elastic net algorithm with ten-fold cross-validation was then applied to develop a sparse machine learning model for predicting depression severity based on the top five features (global functioning, extraversion, neuroticism, emotional abuse in childhood, and somatization). Model generalizability was tested across nine external samples. The model reliably predicted depression severity across all samples (r = 0. 60, SD = 0. 089, p 

Open Access PDF

Concepts Keywords
Easily Adolescent
Females Adult
Global Aged
Inpatients Aged, 80 and over
Neuroticism Cohort Studies
Depression
Female
Humans
Machine Learning
Male
Mental Disorders
Mental Health
Middle Aged
Mood Disorders
Young Adult

Semantics

Type Source Name
disease MESH depressive symptom
drug DRUGBANK Pentaerythritol tetranitrate
disease MESH affective disorder
disease MESH neuroticism
disease MESH emotional abuse
drug DRUGBANK Trestolone
disease MESH schizophrenia
disease MESH Psychosis
pathway REACTOME Metabolism
drug DRUGBANK Coenzyme M
disease MESH major depressive disorder
disease MESH depressive disorder
drug DRUGBANK Spinosad
disease MESH COVID 19
pathway REACTOME Translation
drug DRUGBANK Aspartame
drug DRUGBANK Huperzine B
disease MESH syndromes
disease MESH substance dependence
drug DRUGBANK Ethanol
drug DRUGBANK Kale
drug DRUGBANK Tamoxifen
drug DRUGBANK Serine
drug DRUGBANK Alpha-1-proteinase inhibitor
pathway REACTOME Reproduction
disease MESH Mental Disorders

Original Article

(Visited 5 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *